Suchergebnisse - "Scribano, Maria Lia"

PubPharm (6)

1

Ustekinumab for treating ulcerative colitis : an expert opinion

enthalten in: Expert opinion on biological therapy | 2020

von Biancone, L. | Ardizzone, S. | Armuzzi, A. | +9

2

Use of biosimilars in inflammatory bowel disease : a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2019

von Fiorino, G. | Caprioli, F. | Daperno, M. | +92

3

Ustekinumab in the management of Crohn's disease : Expert opinion

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2018

von Armuzzi, A. | Ardizzone, S. | Biancone, L. | +8

4

Safety of treatments for inflammatory bowel disease : Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2017

von Biancone, L. | Annese, V. | Ardizzone, S. | +50

5

Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-α drugs : report of 3 cases and literature review

enthalten in: Journal of clinical gastroenterology | 2014

von Scribano, M. | Cantoro, L. | Marrollo, M. | +2

CommentIn: J Clin Gastroenterol. 2014 Jul;48(6):476-7. - PMID 24781387

6

Adverse events of IBD therapies

enthalten in: Inflammatory bowel diseases | 2008

von Scribano, M.

ErratumIn: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47

1
[1]